HUMULIN R CARTRIDGE

Main information

  • Trade name:
  • HUMULIN R CARTRIDGE Solution for injection in cartridge 100IU/ML
  • Dosage:
  • 100IU/ML
  • Pharmaceutical form:
  • Solution for injection in cartridge
  • Administration route:
  • Subcutaneous use
  • Units in package:
  • 2X(5X3ML)KWIKPEN Cartridge
  • Prescription type:
  • with prescription
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • HUMULIN R CARTRIDGE Solution for injection in cartridge 100IU/ML
    Czech Republic
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • HUMAN INSULIN
  • Product summary:
  • HUMULIN R CARTRIDGE

Other information

Status

  • Source:
  • SUKL - Státní ústav pro kontrolu léčiv
  • Authorization status:
  • B - medicinal product after change, may be placed on the market
  • Authorization number:
  • 18/ 216/92-C
  • Authorization date:
  • 03-07-2017
  • Last update:
  • 04-04-2018

22-10-2018

EU/3/15/1532 (Sirius Regulatory Consulting EU Limited)

EU/3/15/1532 (Sirius Regulatory Consulting EU Limited)

EU/3/15/1532 (Active substance: Insulin human) - Transfer of orphan designation - Commission Decision (2018)6985 of Mon, 22 Oct 2018

Europe -DG Health and Food Safety

19-6-2018

Insuman (Sanofi-Aventis Deutschland GmbH)

Insuman (Sanofi-Aventis Deutschland GmbH)

Insuman (Active substance: human insulin) - Centralised - Yearly update - Commission Decision (2018)3889 of Tue, 19 Jun 2018

Europe -DG Health and Food Safety